Keefe Bruyette initiated coverage of Blue Foundry Bancorp with a rating of Mkt Perform and set a new price target of $13.25
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/17/2023 | $9.50 | Neutral | Piper Sandler |
| 1/25/2023 | Buy → Neutral | Compass Point | |
| 8/30/2022 | $13.25 | Mkt Perform | Keefe Bruyette |
Transaction Expands Fulton's Presence in Attractive New Jersey MarketsLANCASTER, Pa., April 1, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ:FULT) ("Fulton") today announced the successful completion of its acquisition of Blue Foundry Bancorp (NASDAQ:BLFY) ("Blue Foundry"), Rutherford, N.J. As a result of the acquisition, Fulton advances its growth plan in an important market and becomes a $34 billion financial services company. "We are excited to welcome Blue Foundry Bank customers, employees and shareholders to the Fulton family! Completing the acquisition of Blue
LANCASTER, Pa. and RUTHERFORD, N.J., Feb. 23, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ:FULT) ("Fulton") and Blue Foundry Bancorp (NASDAQ:BLFY) ("Blue Foundry") today jointly announced the receipt of all required regulatory approvals for the previously announced all-stock transaction pursuant to which Fulton will acquire Blue Foundry. Regulatory approvals have been granted by the Board of Governors of the Federal Reserve System and the Office of the Comptroller of the Currency. Blue Foundry's stockholders approved the transaction on January 29, 2026."We are pleas
LANCASTER, Pa. and RUTHERFORD, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Fulton Financial Corporation (NASDAQ:FULT) ("Fulton") and Blue Foundry Bancorp (NASDAQ:BLFY) ("Blue Foundry") today jointly announced the receipt of all required regulatory approvals for the previously announced all-stock transaction pursuant to which Fulton will acquire Blue Foundry. Regulatory approvals have been granted by the Board of Governors of the Federal Reserve System and the Office of the Comptroller of the Currency. Blue Foundry's stockholders approved the transaction on January 29, 2026. "We are pleased to see such strong support from Blue Foundry stockholders and to have received the necessary regulatory
25-NSE - Blue Foundry Bancorp (0001846017) (Subject)
S-8 POS - Blue Foundry Bancorp (0001846017) (Filer)
S-8 POS - Blue Foundry Bancorp (0001846017) (Filer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
Piper Sandler initiated coverage of Blue Foundry Bancorp with a rating of Neutral and set a new price target of $9.50
Compass Point downgraded Blue Foundry Bancorp from Buy to Neutral
Keefe Bruyette initiated coverage of Blue Foundry Bancorp with a rating of Mkt Perform and set a new price target of $13.25
RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $1.9 million, or $0.10 per diluted common share, for the three months ended September 30, 2025, compared to net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, and a net loss of $4.0 million, or $0.19 per diluted common share, for the three months ended September 30, 2024. James D. Nesci, President and Chief Executive Officer, commented, "During the third quarter, we experienced expansion in our net interest margin due to improvements in both yield on
RUTHERFORD, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, October 29, 2025 it will release financial results for the quarter ended September 30, 2025. A copy of the earnings release will be available on the Company's website, https://ir.bluefoundrybank.com/, in the "News" section and on the SEC's website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, October 29, 2025 at 11:00AM (ET) to discuss Third Quarter 2025 Earnings. Blue Foundry Bancorp will address live questions from analysts
RUTHERFORD, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, compared to net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended March 31, 2025, and a net loss of $2.3 million, or $0.11 per diluted common share, for the three months ended June 30, 2024. James D. Nesci, President and Chief Executive Officer, commented, "We are encouraged by the continued improvement experienced this quarter, highlighted by net interest margin expansion, stable
RUTHERFORD, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of John F. Kuntz, Esq. as a Director of both the Company and its subsidiary, Blue Foundry Bank, effective immediately. Kenneth Grimbilas, Chairman, stated, "We are very pleased to have Mr. Kuntz join Blue Foundry's Board of Directors. His extensive knowledge and experience in financial, legal and operational matters will provide additional perspective and depth to the organization. His experience with charitable foundations will also prove to be instrumental at Blue Foundry." Mr. Kuntz most recently served as Senior Executive Vice President and Chief Adm
RUTHERFORD, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of Elizabeth Varki Jobes, Esq. as a Director, effective immediately. James D. Nesci, President and Chief Executive Officer stated, "We are excited to welcome Ms. Jobes to Blue Foundry's Board of Directors. Her years of combined legal and compliance experience leading large, global companies will bring additional perspective to our Board and will prove to be instrumental at Blue Foundry." Ms. Jobes serves as Senior Vice President and Global Chief Compliance Officer of Amryt Pharmaceuticals, a global commercial-stage pharmaceutical company, since 2020. Bef
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)